Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
Recruiting · NCT06561620 · Registry updated 2024-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients | 3-year Disease-free Survival | Recruiting | Phase 4 | 2024-08-22 | NCT06561620 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Cancer Center | Shanghai | China | 5 |